Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Bay City, MI MSA — October 2026
Bay City talent pool shrinks as regulatory pay falls behind national rate.
Bay City unemployment rose to 4.7% and the labor force keeps contracting even as local Regulatory Affairs Specialist pay fell to $92,715, nearly $11,000 below the national median of $103,780.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Bay City unemployment rate: 4.7% — Up from prior month; sharpest MI metro decline in jobs
- Bay City employment change (MoM): -2.2% — Most pronounced decline among Michigan metros, Oct. 2026
- Regulatory Affairs pay gap: $92,715 vs $103,780 — Metro median down vs. national median, both declining
- Michigan bioindustry employment: 47,815 jobs — Up 42% since 2006, hiring growth has moderated since 2022
Key takeaways
Regulatory Affairs pay gap versus national rate continues widening.
Metro advertised pay for Regulatory Affairs Specialists sits over $11,000 below the national median and is declining further, even as national sources flag regulatory affairs as one of the hardest-to-fill credentials in biopharma. Candidates with mobility or remote options have little incentive to anchor to local rates.
CRA compensation is pulling away from the metro's broader wage pattern.
Clinical Research Associate pay rose significantly locally to $96,908, outpacing the national median of $90,065 — a notable reversal given most Bay City roles show flat or declining advertised pay. Experienced CRAs remain the national bottleneck, and this premium suggests local employers are already bidding for scarce talent ahead of any loosening in supply.
Validation Engineer demand signals manufacturing investment and sustained backfill needs.
Advertised pay for Validation Engineers climbed to $110,300 locally, above the stable national median, consistent with broader CDMO and biomanufacturing hiring pressure nationally. Headcount planning for quality and manufacturing functions should treat this as a sustained premium tied to capacity expansion.
Shrinking labor force narrows the build-vs-outsource calculus.
Bay City's labor force has contracted for a decade while statewide participation also declines, meaning the local talent pool available to support in-house R&D or clinical operations keeps thinning. Outsourcing to CROs or CDMOs may increasingly reflect local labor scarcity alongside cost or capability tradeoffs.
Median advertised pay by role — Bay City, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $88,937 | $117,568 | $150,000 | Stable | $130,339 |
| Clinical Research Associate * | $66,560 | $96,908 | $104,011 | Significant increase | $90,065 |
| Lab Technician * | $37,606 | $45,441 | $46,930 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $68,604 | $92,715 | $110,788 | Significant decline | $103,780 |
| Clinical Data Manager * | $96,750 | $128,800 | $151,550 | Stable | $123,653 |
| Biostatistician * | $111,745 | $130,908 | $156,868 | Stable | $131,958 |
| Validation Engineer * | $82,514 | $110,300 | $120,327 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Bay City MSA unemployment climbed to 4.7% in October against a backdrop of month-over-month employment contraction of 2.2% — the sharpest decline among Michigan metros — while the local labor force continues a longer structural slide of 1.9% since 2016. Regional labor supply is shrinking even as Michigan's bioindustry sector, now 47,815 jobs statewide, competes for the same shrinking pool of regulatory, quality, and manufacturing talent that biotech and pharma employers nationally say is the hardest to fill.
What it means
Shrinking local labor supply compounds the national bottleneck in regulatory affairs, clinical operations, and biomanufacturing talent, meaning Bay City-based life sciences employers face a smaller bench to draw from just as demand for these credentials intensifies statewide. Regulatory Affairs Specialist pay locally fell to $92,715 against a national median of $103,780 — a divergence that may reflect fewer competing local employers, independent of skill value, and could leave Bay City employers exposed if candidates benchmark against national postings. Organizations should evaluate whether local regulatory and quality compensation is keeping pace with national advertised rates, particularly before a build-vs-outsource decision locks in headcount assumptions for the next budget cycle.
Looking ahead
Early indicator: Watch whether Bay City's sharp October employment decline (-2.2% month-over-month) reverses or deepens in November data; a deepening trend would further tighten an already thin specialist labor pool for regulatory and quality roles.
Emerging pressure point: Track whether the Regulatory Affairs pay gap between Bay City and national advertised rates continues widening. A persistent gap raises retention risk for employers who cannot match remote or hybrid regulatory postings from other markets.
Potential inflection point: Michigan's halted MI BioTalent Connect program leaves a pipeline gap for manufacturing, quality, and clinical training; watch for any state-level replacement funding announcement that could ease Bay City's credential scarcity over the next two budget cycles.
Worth watching: Validation Engineer and CRA pay premiums locally suggest active bidding for scarce talent; monitor whether neighboring Michigan metros show similar premiums, which would indicate a statewide tightening extending beyond Bay City.
Sources
- Michigan State Office of Management and Budget — Bay City MSA employment decline of 2.2% month-over-month, largest among MI metros
- Michigan State Office of Management and Budget — Bay City labor force decline of 1.9% since October 2016
- Michigan Biosciences Industry report — Michigan bioindustry employment reached 47,815 jobs in 2024, up 42% since 2006
- Biopharma industry workforce survey — Regulatory affairs, clinical operations, and biomanufacturing cited as hardest pharma roles to fill in 2026
- Life sciences clinical staffing research — Experienced CRAs remain the primary bottleneck in clinical talent supply
- Michigan Strategic Fund — MI BioTalent Connect $645M workforce program halted before 2026 launch
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.